Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Telcagepant is an orally active antagonist of calcitonin gene-related peptide (CGRP) receptor (Kis: 0.77 nM and 1.2 nM for human and rhesus CGRP receptors, respectively).
Description | Telcagepant is an orally active antagonist of calcitonin gene-related peptide (CGRP) receptor (Kis: 0.77 nM and 1.2 nM for human and rhesus CGRP receptors, respectively). |
Targets&IC50 | CGRP (human):(ki)0.77 nM, CGRP (rhesus):1.2 nM(ki) |
In vitro | Telcagepant shows affinity (Ki) for the canine and rat receptors, with values of 1204 nM and 1192 nM (n=10), respectively. Telcagepant displays saturable binding to SK-N-MC membranes with a KD of 1.9 nM and Bmax of 479 fmol/mg protein. Telcagepant effectively blocks human α-CGRP-stimulated cAMP responses in the human CGRP receptor-expressing HEK293 cells (IC50: 2.2 nM)[1]. Telcagepant also displays saturable binding to rhesus cerebellum homogenate (KD: 1.3 nM and Bmax of 20 fmol/mg)[2]. |
In vivo | Telcagepant (MK-0974) exhibits linear pharmacokinetics within a 0.5-10 mg/kg intravenous dosage range in monkeys. However, when administered orally at doses between 5-30 mg/kg, the area under the plasma concentration-time curve (AUC) increases in a manner that is 15-fold over dose-proportional. Furthermore, administering Telcagepant as an intravenous bolus at 1 mg/kg highlights the time-dependent nature of the antagonist’s efficacy, which aligns with plasma concentrations[1][3]. |
Synonyms | MK-0974 |
Molecular Weight | 566.52 |
Formula | C26H27F5N6O3 |
CAS No. | 781649-09-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (88.26 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Telcagepant 781649-09-0 Others MK 0974 MK-0974 MK0974 inhibitor inhibit